Investors

Recent Event

CHEST 2026

Latest Financial Results

Q2 2026

Quarter Ended

Earnings Release

10-Q

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2025

Company Information

Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.

IR Contacts

Headquarters

Achieve Life Sciences, Inc.
22722 29th Dr. SE
Suite 100
Bothell, WA 98021
United States
T: 425-686-1500

Investor Relations

Nicole Jones
T: 425-686-1510
ir@achievelifesciences.com